APHA

COM:APHAGE

Adaptive Phage Therapeutics

  • Privately Held

Adaptive Phage Therapeutics (APT) is a clinical-stage biotechnology company focused on developing safe, effective, and durable antimicrobial therapeutics to combat bacterial infections, particularly multi-drug resistant (MDR) pathogens.

peer of

investor of

competitor of